AQP4 and central nervous system cancer: The motility of glioma U87MG cells was increased when AQP4 was overexpressed or Kyn was supplemented, while Kyn supplementation could not restore the cell motility decreased by AhR inhibition and AQP4 knockdown (Fig. 6g).